Tag: data monitoring committee

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…

ME Desk

Achieving Smart Safety Monitoring: Navigating Risks in Todayโ€™s Complex Trials

Clinical trials form the cornerstone of evidence-based medicine. They provide the data…

Alina Panourgia